Press Releases

February 27, 2020 at 6:50 AM EST

Summary Toggle Rockwell Medical, Inc. Provides Business Update

-- Continued progress for Triferic ® portfolio -- -- 77% increase in the number of clinics under contract -- WIXOM, Mich. , Feb. 27, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the "Company"), a biopharmaceutical company dedicated to transforming anemia

PDF Version
February 6, 2020 at 4:30 PM EST

Summary Toggle Rockwell Medical, Inc. to Present at 2020 BIO CEO & Investor Conference

WIXOM, Mich. , Feb. 06, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul , Chief Executive Officer, will present at the 2020 BIO CEO & Investor Conference as follows: Date: Monday, February 10, 2020 Time: 9:15 a.m.

PDF Version
February 4, 2020 at 9:21 AM EST

Summary Toggle Rockwell Medical Announces Pricing of $7.5 Million Public Offering of Common Stock

WIXOM, Mich. , Feb. 04, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today announced the pricing of its underwritten

PDF Version
February 3, 2020 at 4:01 PM EST

Summary Toggle Rockwell Medical Announces Proposed Public Offering of Common Stock

WIXOM, Mich. , Feb. 03, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today announced an underwritten public offering

PDF Version
January 14, 2020 at 9:30 PM EST

Summary Toggle Rockwell Medical, Inc. Enters into Exclusive License and Supply Agreements with Sun Pharma for the Rights to Commercialize Triferic® in India

- Sizable and growing market opportunity with 120,000+ patients receiving hemodialysis annually – WIXOM, Mich. , Jan. 14, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and

PDF Version
January 9, 2020 at 5:30 PM EST

Summary Toggle Rockwell Medical, Inc. Appoints Russell H. Ellison, MD, MSc, to Board of Directors

WIXOM, Mich. , Jan. 09, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, announced today the appointment of Russell H.

PDF Version
January 8, 2020 at 4:30 PM EST

Summary Toggle Rockwell Medical, Inc. to Present at Biotech Showcase 2020

WIXOM, Mich. , Jan. 08, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul , Chief Executive Officer, and Angus Smith , Chief Financial Officer, will present at the Biotech Showcase 2020 as follows: Date:

PDF Version
November 21, 2019 at 6:50 AM EST

Summary Toggle Rockwell Medical, Inc. to Present at 31st Annual Piper Jaffray Healthcare Conference

WIXOM, Mich. , Nov. 21, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul , Chief Executive Officer, will present at the 31st Annual Piper Jaffray Healthcare Conference as follows: Date: Tuesday, December 3, 2019

PDF Version
November 20, 2019 at 6:50 AM EST

Summary Toggle Rockwell Medical, Inc. Expands Medical Capabilities

– Company adds experienced medical executive to management team and leading nephrologists to Medical Advisory Board – – Objective to become a leading medical organization in the field of dialysis – WIXOM, Mich. , Nov. 20, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc.

PDF Version
November 11, 2019 at 4:05 PM EST

Summary Toggle Rockwell Medical, Inc. Reports Third Quarter 2019 Financial Results

– Company reports first full quarter of results for Dialysate Triferic, highlighted by greater than 75% conversion rate from Triferic Evaluation Program – – Signs leading East Coast academic medical center as first Center of Excellence – WIXOM, Mich. , Nov.

PDF Version